These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8808807)

  • 1. [Risk factor, natural history and prognosis of the patients with arteriosclerosis obliterans].
    Ito M; Mishima Y
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):476-80. PubMed ID: 8808807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherosclerosis obliterans of the lower extremities in Thai patients.
    Mutirangura P; Ruangsetakit C; Wongwanit C; Sermsathanasawadi N; Chinsakchai K
    J Med Assoc Thai; 2006 Oct; 89(10):1612-20. PubMed ID: 17128835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Medical treatment of arteriosclerosis obliterans (ASO)].
    Matsuo H
    Nihon Geka Gakkai Zasshi; 1996 Jul; 97(7):520-5. PubMed ID: 8808815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology and diagnosis for arteriosclerosis obliterans].
    Sasaki H; Konisi K
    Rinsho Byori; 2002 Aug; 50(8):802-6. PubMed ID: 12373817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation.
    Novo S; Avellone G; Di Garbo V; Abrignani MG; Liquori M; Panno AV; Strano A
    Int Angiol; 1992; 11(3):218-29. PubMed ID: 1460357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and biochemical parameters of patients with vascular stenosis in the lower extremities in the stage of intermittent claudication].
    Kozlovszky B; Mohácsi A; Bajnok L; Csiba L; Országh I; Fülöp T
    Orv Hetil; 1995 Apr; 136(16):817-22. PubMed ID: 7644187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
    Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
    Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factor distribution according to the obesity degree in patients with coronary artery disease].
    Sönmez K; Akçakoyun M; Demir D; Akçay A; Pala S; Duran NE; Bakal RB; Gençbay M; Değertekin M; Turan F
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):203-10. PubMed ID: 12223326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Why are cardiologists to be concerned about obliterating arterial disease of the lower leg?].
    Fisicaro M
    Ital Heart J Suppl; 2003 Apr; 4(4):306-18. PubMed ID: 12784766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of lipoprotein fractions in men with arteriosclerosis obliterans].
    Karádi I; Szabolcs Z; Szénási P; Hosszúfalusi N; Császár A; Kusztos R; Romics L
    Orv Hetil; 1989 Jul; 130(28):1489-92. PubMed ID: 2748165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF; Comeglio M; Colella A
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention of arteriosclerosis].
    Hoffmann U; Leu AJ
    Praxis (Bern 1994); 1996 Sep; 85(39):1201-5. PubMed ID: 8927904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilation and reduced distensibility of carotid artery in patients with abdominal aortic aneurysms.
    Makita S; Ohira A; Tachieda R; Itoh S; Moriai Y; Niinuma H; Nakamura M; Hiramori K
    Am Heart J; 2000 Aug; 140(2):297-302. PubMed ID: 10925346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life in patients with risk factors of coronary heart disease].
    Kwaśniewska M; Drygas W
    Przegl Lek; 2005; 62(9):863-70. PubMed ID: 16541719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriosclerosis obliterans (ASO)].
    Koshikawa M; Ikeda U
    Nihon Rinsho; 2010 May; 68(5):926-9. PubMed ID: 20446594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.